As anti-VEGF therapy has demonstrated efficacy in patients with advanced CRC (Hurwitz et al, 2004), further study of VEGF/VEGFR interactions in endothelial and, perhaps, tumour cells is warranted (Figure 7). Here, KDR is linked to colorectal carcinoma.